XML 68 R54.htm IDEA: XBRL DOCUMENT

Stockholders' Equity, Common Stock Purchase Warrants, and Noncontrolling Interest - Schedule of Noncontrolling Interest (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
NCI - equity (deficit) - beginning of period	$ (814)
Net loss attributable to NCI	(1,612)	$ (811)
NCI - equity (deficit) - end of period	(2,369)	(814)
Non-controlling Interest [Member]
NCI - equity (deficit) - beginning of period	(814)	(161)
NCI - equity (deficit) - end of period	(2,369)	(814)
Non-controlling Interest [Member] \| Solys Diagnostics Inc. [Member]
Minority Interest investment Solys Diagnostics Inc		889
Minority Interest share subscription receivable - Solys Diagnostics Inc.		(889)
Net loss attributable to NCI	(109)	(10)
Non-controlling Interest [Member] \| Lucid Diagnostics Inc [Member]
Lucid Diagnostics Inc. 2018 Equity Plan stock option exercise	5
Net loss attributable to NCI	(1,503)	(801)
Stock-based compensation expense - Lucid Diagnostics Inc 2018 Equity Plan	$ 52	$ 158

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).

+ References + Details